CRISPR-activated patient fibroblasts for modeling of familial Alzheimer’s disease.
Inoue K*.
Neurosci Res. 2021; 172: 7-12.
CRISPR-activated patient fibroblasts for modeling of familial Alzheimer’s disease.
Inoue K*.
Neurosci Res. 2021; 172: 7-12.